Our Clinical Trial Experience With Tuberculosis
The FHI Clinical project team has partnered with companies to conduct clinical trials as well as epidemiological and observational studies for tuberculosis in 30 countries worldwide.
Our Clinical Trial Experience With HIV
The FHI Clinical project team has partnered with companies to conduct clinical trials as well as behavioral and observational studies for HIV in 24 countries worldwide.
Our Clinical Trial Experience With Malaria
For nearly 20 years, the FHI Clinical project team has partnered with companies developing and deploying vaccines, treatments and preventive devices for malaria in 38 countries worldwide.
Our Clinical Trial Experience With Oncology
For nearly 20 years, the FHI Clinical project team has partnered with companies developing and deploying vaccines, treatments and diagnostic tests for multiple oncology indications.
Coronaviruses Fact Sheet
Discovered in the 1960s, coronaviruses (CoV) are a large group of RNA viruses in the family Coronaviridae that cause disease in humans and animal species. Human illness includes respiratory infections that range from the common cold to viral (direct) or bacterial (indirect) pneumonia and are especially serious in infants and at-risk adults. There are seven known coronavirus types/strains.
Our Clinical Trial Experience With Ebola Virus Disease
Since 1976, Ebola virus disease outbreaks have primarily occurred in eleven countries: Democratic Republic of the Congo, Gabon, Guinea, Liberia, Mali, Nigeria, Republic of Congo, Sierra Leone, Sudan and Uganda. Although it is generally rare, it is often fatal, with death rates ranging from 25 to 90% in past outbreaks (average case fatality rate, 50%). No treatment or vaccine is currently approved, but there are several promising vaccines and treatments under development.
Dengue Fever Fact Sheet
Dengue fever, a mosquito-borne tropical disease, is the most common and important arthropod-borne (arboviral) illness in humans. It is caused by four serotypes of the dengue virus, of which more than one can circulate during an epidemic. Infection with one serotype confers lifelong homotypic immunity to that serotype and a brief period (~2 years) of partial heterotypic immunity to other serotypes. However, an individual can eventually be infected by all four serotypes.
Schistosomiasis Fact Sheet
Also known as snail fever, schistosomiasis is caused by parasitic flatworms called schistosomes. It is spread through contact with contaminated fresh water. Most human cases are caused by specific species of flatworms. In tropical countries, it is second only to malaria among parasitic diseases with the greatest economic impact. Schistosomiasis affects almost 200 million individuals per year, with most cases occurring in Africa, Asia and South America.
Lassa Fever Fact Sheet
Lassa fever is a type of hemorrhagic fever caused by the Lassa virus and is mainly transmitted by rodents. The virus was first detected in 1969 in the town of Lassa, in Borno State, Nigeria; hence, its name. Lassa is endemic to West Africa, specifically Nigeria, Liberia, Sierra Leone and Guinea. A significant number of individuals infected by the Lassa virus (~80%) do not appear to develop symptoms. The case fatality rate (CFR) has been reported to be upwards of 70%
Cryptosporidiosis Fact Sheet
Cryptosporidium infection (cryptosporidiosis) is a diarrheal disease caused by tiny, one-celled Cryptosporidium parasites representing at least 15 genotypically and phenotypically diverse species. When these parasites enter the body, they travel to the distal small intestine and burrow into the intestinal walls. After 1-2 weeks, they are shed and excreted in feces. Infection can also occur in the respiratory tract.
